Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jentzen

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Nuklearmedizin. Nuclear Medicine|July 10, 2012
Estimation of tumour mass in patients with differentiated thyroid carcinoma using serum thyroglobulinS J Rosenbaum-Krumme, M Wieduwilt, J Nagarajah, et al.
Nuklearmedizin. Nuclear Medicine|May 20, 2015
Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients. Dosimetry-based model for estimationW Jentzen, A-S Moldovan, M Ruhlmann, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 7, 2007
124-iodine positron emission tomography/computed tomography dosimetry in pediatric patients with differentiated thyroid cancerL S Freudenberg, W Jentzen, R J Marlowe, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 11, 2007
[The effect of different chemoembolization materials on CT-based attenuation correction in PET/CT]T-A Heusner, U Fronz, W Jentzen, et al.
Nuklearmedizin. Nuclear Medicine|August 11, 2007
124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impactL S Freudenberg, W Jentzen, R Görges, et al.
European Journal of Endocrinology|July 5, 2005
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomyR Görges, M Maniecki, W Jentzen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2008
Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PETL S Freudenberg, G Antoch, A Frilling, et al.
Biochemistry|May 16, 1998
Protein-induced changes in nonplanarity of the porphyrin in nickel cytochrome c probed by resonance Raman spectroscopyJ G Ma, M Laberge, X Z Song, et al.
European Radiology|March 17, 2004
Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case reportL S Freudenberg, G Antoch, R Görges, et al.
Nuklearmedizin. Nuclear Medicine|November 7, 2002
[Combination PET/CT with 124I positron rays in metastatic follicular thyroid carcinoma]R Görges, G Antoch, W Brandau, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Nuklearmedizin. Nuclear Medicine|July 10, 2012
Estimation of tumour mass in patients with differentiated thyroid carcinoma using serum thyroglobulinS J Rosenbaum-Krumme, M Wieduwilt, J Nagarajah, et al.
Nuklearmedizin. Nuclear Medicine|May 20, 2015
Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients. Dosimetry-based model for estimationW Jentzen, A-S Moldovan, M Ruhlmann, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 7, 2007
124-iodine positron emission tomography/computed tomography dosimetry in pediatric patients with differentiated thyroid cancerL S Freudenberg, W Jentzen, R J Marlowe, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 11, 2007
[The effect of different chemoembolization materials on CT-based attenuation correction in PET/CT]T-A Heusner, U Fronz, W Jentzen, et al.
Nuklearmedizin. Nuclear Medicine|August 11, 2007
124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impactL S Freudenberg, W Jentzen, R Görges, et al.
European Journal of Endocrinology|July 5, 2005
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomyR Görges, M Maniecki, W Jentzen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2008
Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PETL S Freudenberg, G Antoch, A Frilling, et al.
Biochemistry|May 16, 1998
Protein-induced changes in nonplanarity of the porphyrin in nickel cytochrome c probed by resonance Raman spectroscopyJ G Ma, M Laberge, X Z Song, et al.
European Radiology|March 17, 2004
Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case reportL S Freudenberg, G Antoch, R Görges, et al.
Nuklearmedizin. Nuclear Medicine|November 7, 2002
[Combination PET/CT with 124I positron rays in metastatic follicular thyroid carcinoma]R Görges, G Antoch, W Brandau, et al.
Pageof 3